{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:32:56Z","timestamp":1793068376265,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009881.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000}}],"reference-count":105,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009881.pub3","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:42:52Z","timestamp":1789555372000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progesterone receptor modulators for endometriosis"],"prefix":"10.1002","volume":"2026","author":[{"given":"Alexandros Loukas","family":"Grammatis","sequence":"additional","affiliation":[{"name":"Birmingham Women's Fertility Centre; Birmingham Women's Hospital NHS Foundation Trust; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Gibbons","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, Fertility and Obstetrics; Rigshospitalet; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberechi N","family":"Anucha","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M","family":"Becker","sequence":"additional","affiliation":[{"name":"Nuffield Department of Women's & Reproductive Health; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"10.1002\/14651858.CD009881.pub3-BIB0001|cit1","volume-title":"Berek & Novak's Gynecology","author":"Berek","year":"2019"},{"issue":"13","key":"10.1002\/14651858.CD009881.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMra1810764","article-title":"Endometriosis","volume":"382","author":"Zondervan","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub3-BIB0003|cit3","first-page":"1","article-title":"ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis","volume":"2022","author":"Becker","year":"2022","journal-title":"Human Reproduction (Open Access)"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-8545(05)70302-8","article-title":"Epidemiology of endometriosis","volume":"24","author":"Eskenazi","year":"1997","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0005|cit5","first-page":"251","article-title":"Laparoscopy in the diagnosis and management of pelvic pain in adolescents","volume":"24","author":"Goldstein","year":"1980","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nature Reviews Endocrinology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0007|cit7","unstructured":"Uterine gland formation in uterus and ovarian sarcoma Wien: Druck von Carl Ueberreuter 1860"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9378(15)30003-X","article-title":"Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the pelvic cavity","volume":"14","author":"Sampson","year":"1927","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.fertnstert.2018.10.013","article-title":"Pathogenesis of endometriosis: the genetic\/epigenetic theory","volume":"111","author":"Koninckx","year":"2019","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0010|cit10","first-page":"32","article-title":"Hormonal therapy for endometriosis: from molecular research to bedside","volume":"5","author":"Tosti","year":"2016","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"4","key":"10.1002\/14651858.CD009881.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/humupd\/dmz014","article-title":"The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis","volume":"25","author":"Shigesi","year":"2019","journal-title":"Human Reproduction Update"},{"issue":"10","key":"10.1002\/14651858.CD009881.pub3-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005262.pub4","article-title":"Laparoscopic surgery for endometriosis","author":"Bafort","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1471-0528.14793","article-title":"Impact of endometriosis on risk of further gynaecological surgery and cancer: a national cohort study","volume":"125","author":"Saraswat","year":"2018","journal-title":"BJOG"},{"issue":"3","key":"10.1002\/14651858.CD009881.pub3-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009590.pub2","article-title":"Endometriosis: an overview of Cochrane Reviews","author":"Brown","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009881.pub3-BIB0015|cit15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002122.pub2","article-title":"Progestagens and anti-progestagensfor pain associated with endometriosis","author":"Brown","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009881.pub3-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014788.pub2","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","author":"Veth","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009881.pub3-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000068.pub2","article-title":"Danazol for pelvic pain associated with endometriosis","author":"Farquhar","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD009881.pub3-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001019.pub3","article-title":"Oral contraceptivesfor pain associated with endometriosis","author":"Brown","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009881.pub3-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000155.pub2","article-title":"Ovulation suppression for endometriosis for women with subfertility","author":"Hughes","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1477-7827-9-89","article-title":"Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review","volume":"9","author":"Ferrero","year":"2011","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0889-8545(02)00057-8","article-title":"Medical management of endometriosis-associated pain","volume":"30","author":"Mahutte","year":"2003","journal-title":"Obstetrics & Gynecology Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD009881.pub3-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/humupd\/dmy020","article-title":"Is it time for a paradigm shift in drug research and development in endometriosis\/adenomyosis?","volume":"24","author":"Guo","year":"2018","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2217\/WHE.10.79","article-title":"Use of mifepristone to treat endometriosis: a review of clinical trials and trial-like studies conducted in China","volume":"7","author":"Guo","year":"2011","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2174\/0929867323666160428105310","article-title":"Current progresses and trends in the development of progesterone receptor modulators","volume":"23","author":"Li","year":"2016","journal-title":"Current Medicinal Chemistry"},{"issue":"9","key":"10.1002\/14651858.CD009881.pub3-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3390\/ph17091248","article-title":"Effects, doses, and applicability of gestrinone in estrogen-dependent conditions and post-menopausal women","volume":"17","author":"Renke","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/jcem.87.1.8140","article-title":"Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 days","volume":"87","author":"Brown","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/GCO.0b013e32832e07e8","article-title":"Clinical utility of progesterone receptor modulators and their effect on the endometrium","volume":"21","author":"Spitz","year":"2009","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis is a chronic systemic disease: clinical challenges and novel innovations","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1210\/endrev\/bnaa012","article-title":"Selective progesterone receptor modulators-mechanisms and therapeutic utility","volume":"41","author":"Islam","year":"2020","journal-title":"Endocrine Review"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/rep.0.1240167","article-title":"Anti-proliferative effects of progesterone antagonists in the primate endometrium: a potential role for the androgen receptor","volume":"124","author":"Brenner","year":"2002","journal-title":"Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2005-864035","article-title":"Progesterone receptor antagonists and the endometrial antiproliferative effect","volume":"23","author":"Brenner","year":"2005","journal-title":"Seminars in Reproductive Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009881.pub3-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010770.pub2","article-title":"Selective progesterone receptor modulators (SPRMs) for uterine fibroids","author":"Murji","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0033|cit33","unstructured":"European Medicines Agency https:\/\/www.ema.europa.eu\/en\/documents\/referral\/ulipristal-acetate-5mg-medicinal-products-article-31-referral-chmp-scientific-conclusions-and-prac-assessment-report_en.pdf (accessed prior to 27 July 2026)"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009881.pub3-BIB0034|cit34","first-page":"S83","article-title":"Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil","volume":"82","author":"Chwalisz","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(16)58022-4","article-title":"Treatment of endometriosis with the antiprogesterone mifepristone (RU486)","volume":"65","author":"Kettel","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0036|cit36","first-page":"551","article-title":"Mifepristone: auxiliary therapeutic use in cancer and related disorders","volume":"43","author":"Koide","year":"1998","journal-title":"Journal of Reproductive Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009881.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1210\/jc.2003-031945","article-title":"Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor","volume":"89","author":"Narvekar","year":"2004","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD009881.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Modern Pathology"},{"issue":"6","key":"10.1002\/14651858.CD009881.pub3-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/PGP.0000000000000450","article-title":"Endometrial changes in surgical specimens of perimenopausal patients treated with ulipristal acetate for uterine leiomyomas","volume":"3","author":"Nogales","year":"2018","journal-title":"International Journal of Gynecologic Pathology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0039-128X(00)00190-2","article-title":"Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium","volume":"65","author":"Chwalisz","year":"2000","journal-title":"Steroids"},{"issue":"6","key":"10.1002\/14651858.CD009881.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/humupd\/dmm023","article-title":"Progesterone receptor modulators and the endometrium: changes and consequences","volume":"13","year":"2007","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0043|cit43","first-page":"2897\u2013902","article-title":"Progesterone receptor isoform A but not B is expressed in endometriosis","volume":"85","author":"Attia","year":"2000","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1471-0528.16157","article-title":"A core outcome set for future endometriosis research: an international consensus development study","volume":"127","author":"Duffy","year":"2020","journal-title":"BJOG"},{"issue":"6","key":"10.1002\/14651858.CD009881.pub3-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0002-9378(81)90478-6.","article-title":"Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness","volume":"139","author":"Biberoglu","year":"1981","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0046|cit46","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/www.cochrane.org\/handbook 2022"},{"issue":"7","key":"10.1002\/14651858.CD009881.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0049|cit49","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/www.cochrane.org\/handbook 2022"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0050|cit50","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 Available online at the Cochrane Handbook Chapter 23 page."},{"key":"10.1002\/14651858.CD009881.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMsm1605385","article-title":"Per-protocol analyses of pragmatic trials","volume":"377","author":"Hern\u00e1n","year":"2017","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0052|cit52","unstructured":"Deeks JJ Higgins JPT Altman DG McKenzie JE Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.cochrane.org"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0053|cit53","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2021"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0054|cit54","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:www.cochrane.org\/handbook 2022"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/GCO.0b013e32832e07e8","article-title":"Clinical utility of progesterone receptor modulators and their effect on the endometrium","volume":"21","author":"Spitz","year":"2009","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0056|cit56","volume-title":"Textbook of Endometriosis","author":"Spitz","year":"2009"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0057|cit57","unstructured":"A study to evaluate the safety and effectiveness of three asoprisnil doses in the treatment of women with endometriosis https:\/\/clinicaltrials.gov\/study\/NCT00160446"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9378(97)70504-0","article-title":"Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis","volume":"176","author":"Dawood","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD009881.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0015-0282(16)55793-8","article-title":"A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis","volume":"59","author":"Worthington","year":"1993","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1471-0528.1995.tb09160.x","article-title":"Updating the clinical experience in endometriosis - the European perspective","volume":"102 Suppl 12","author":"Bromham","year":"1995","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/01443619509015498","article-title":"A multicentre comparative study of gestrinone and danazol in the treatment of endometriosis","volume":"15","author":"Bromham","year":"1995","journal-title":"Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub3-BIB0062|cit62","first-page":"51","article-title":"Treatment with 5 mg or 25 mg of mifepristone daily for six months. A randomized double-blind study","volume":"55","author":"Carbonell","year":"2012","journal-title":"Progresos de Obstetricia y Ginecologia"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jrhm.2015.09.001","article-title":"Mifepristone 2.5, 5, 10 mg versus placebo in the treatment of endometriosis","volume":"2","author":"Carbonell","year":"2016","journal-title":"Journal of Reproductive Health and Medicine"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0015-0282(16)60666-0","article-title":"Gestrinone versus danazol in the treatment of endometriosis","volume":"51","author":"Fedele","year":"1989","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0015-0282(16)58682-8","article-title":"Gestrinone versus a gonadotropin releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomised, double-blind study","volume":"66","author":"Gestrinone Italian Study Group","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0015-0282(16)53273-7","article-title":"A randomised, double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis","volume":"53","author":"Hornstein","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.31838\/ijprt\/15.2.168","article-title":"Mifepristone versus dienogest in medical management of endometrioma up to 6 cm diameter: a prospective observational study","volume":"15","author":"Bisal","year":"2025","journal-title":"International Journal of Pharmaceutical Research and Technology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0068|cit68","unstructured":"Bulun S Ulipristal for endometriosis-related pelvic pain ClinicalTrials.gov Identifier:NCT02213081"},{"issue":"5","key":"10.1002\/14651858.CD009881.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","journal-title":"Fertility Sterility"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000414891","article-title":"Endometriosis therapy with gestrinone by oral, vaginal or parenteral administration","volume":"16","author":"Coutinho","year":"1987","journal-title":"Contributions to gynecology and obstetrics"},{"issue":"3 (Special)","key":"10.1002\/14651858.CD009881.pub3-BIB0071|cit71","first-page":"1157","article-title":"Effect of laparoscopy combined with mifepristone in the treatment of endometriosis and drug reaction analysis","volume":"31","author":"Li","journal-title":"Pak J Pharm Sci"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub3-BIB0072|cit72","first-page":"89","article-title":"The efficacy and safety of a 19 nor-steroid in the treatment of endometriosis","volume":"58","author":"Yang","year":"1996","journal-title":"Chinese Medical Journal (Taipei) \/ 1996;58(2):89-96"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0015-0282(16)58022-4","article-title":"Treatment of endometriosis with the antiprogesterone mifepristone (RU486)","volume":"65","author":"Kettel","year":"1996","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9378(98)70316-3","article-title":"Preliminary report on the treatment of endometriosis with low dose mifepristone (RU 486)","volume":"178","author":"Kettel","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0075|cit75","first-page":"33","volume-title":"Medical Management of Endometriosis","author":"Mettler","year":"1984"},{"issue":"12","key":"10.1002\/14651858.CD009881.pub3-BIB0076|cit76","first-page":"717","article-title":"Mifepristone following conservative surgery in the treatment of endometriosis","volume":"36","author":"Jiang","year":"2001","journal-title":"Zhonghua fu chan ke za zhi"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0077|cit77","first-page":"199","article-title":"Long term follow-up of endometriosis after two different therapies (gestrinone and buserelin)","volume":"23","author":"Nieto","year":"1996","journal-title":"Clinical & Experimental Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD009881.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF02836527","article-title":"Comparative study of Yiweining and gestrinone for post-operational treatment of stage 3 endometriosis","volume":"12","author":"Yang","year":"2006","journal-title":"Chinese Journal of Integrative Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009881.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"350","DOI":"10.12891\/ceog2086.2016","article-title":"Effect of mifepristone in the different treatments of endometriosis","volume":"43","author":"Zhang","year":"2016","journal-title":"Clinical & Experimental Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD009881.pub3-BIB0080|cit80","first-page":"676","article-title":"Clinic curative effects of low-dose mifepristone in treating recurrent endometriosis and changes in ovarian function and serum cortisol level","volume":"34","author":"Zhao","year":"2008","journal-title":"Journal of Jilin University Medicine"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.12669\/pjms.345.15574","article-title":"Clinical evaluation of laparoscopic surgery combined with triptorelin acetate in patients with endometriosis and infertility","volume":"34","author":"Xue","year":"2018","journal-title":"Pak J Med Sci"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub3-BIB0082|cit82","first-page":"13","article-title":"Gestrinone vs. danazol: results of the treatment of stage I and II endometriosis","volume":"10","author":"Mota-Gonz\u00e1lez","year":"1996","journal-title":"Perinatolog\u00eda y reproducci\u00f3n humana"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1471-0528.1980.tb04607.x","article-title":"Treatment of endometriosis: a study of medical management","volume":"87","author":"Noble","year":"1980","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0084|cit84","unstructured":"Clinical study and effectiveness evaluation of Chinese herbal medicine for pelvic endometriosis https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR-TRC-10000808"},{"issue":"5","key":"10.1002\/14651858.CD009881.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1268\u20131272","DOI":"10.12669\/pjms.325.10772","article-title":"Therapeutic effects of mifepristone combined with Gestrinone on patients with endometriosis","volume":"32","author":"Xue","year":"2016","journal-title":"Pakistan journal of medical sciences"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s11655-012-1247-z","article-title":"Controlling the recurrence of pelvic endometriosis after a conservative operation: Comparison between Chinese herbal medicine and western medicine","volume":"19","author":"Zhang","year":"2013","journal-title":"Chinese Journal of Integrative Medicine"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bmj.294.6567.272","article-title":"Impact of gestrinone on the course of asymptomatic endometriosis","volume":"294","author":"Thomas","year":"1987","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0088|cit88","unstructured":"Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis https:\/\/clinicaltrials.gov\/study\/NCT00556075"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0089|cit89","unstructured":"Study Evaluating the Safety and Efficacy of Proellex\u00ae in the Treatment of Endometriosis-extension Study https:\/\/clinicaltrials.gov\/study\/NCT00958412"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0090|cit90","unstructured":"Open-Label Extension Study to ZPE-202 https:\/\/clinicaltrials.gov\/study\/NCT01961908"},{"issue":"2","key":"10.1002\/14651858.CD009881.pub3-BIB0091|cit91","first-page":"189","article-title":"Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial","volume":"5","author":"Taylor","journal-title":"F S Rep"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0092|cit92","unstructured":"Assess safety and efficacy of vilaprisan in subjects with endometriosis https:\/\/clinicaltrials.gov\/study\/NCT03573336"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0093|cit93","unstructured":"A study to evaluate the safety and effectiveness of asoprisnil in the treatment of women with endometriosis https:\/\/clinicaltrials.gov\/study\/NCT00160433"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0094|cit94","unstructured":"Safety and efficacy of telapristone acetate (Proellex\u00ae) in the treatment of premenopausal women with confirmed symptomatic endometriosis https:\/\/clinicaltrials.gov\/study\/NCT01728454"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub3-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"2527352","DOI":"10.1080\/07853890.2025.2527352","article-title":"Rationale and design of the GLADE study: a randomised, multicentre, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain","volume":"57","author":"Malavasi","year":"2025","journal-title":"Annals of Medicine"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0096|cit96","unstructured":"Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis https:\/\/clinicaltrials.gov\/study\/NCT06543550"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"108519","DOI":"10.1016\/j.maturitas","article-title":"Comparison between the effects of implantable gestrinone and oral dienogest in the treatment of endometriosis: randomised controlled clinical trial","volume":"199","author":"Assis Florentino","year":"2025","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0098|cit98","unstructured":"Parallel group, blinded, multi-centre study of mifepristone in patients with endometriosis https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2018-002367-26-BG"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub3-BIB0099|cit99","first-page":"136","article-title":"Systematic review of endometriosis pain assessment: how to choose a scale?","volume":"21","author":"Bourdel","year":"2015","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD009881.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2008.09.056","article-title":"Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting","volume":"93","author":"Vincent","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD009881.pub3-BIB0101|cit101","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009881.pub2","article-title":"Progesterone receptor modulators for endometriosis","author":"Fu","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009881.pub3-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/AOG.0b013e318291f299","article-title":"Lack of transparency of clinical trials on endometriosis","volume":"121","author":"Guo SW Evers","year":"2013","journal-title":"Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD009881.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/pharmaceutics17050638","article-title":"Safety profile of gestrinone: a systematic review","volume":"17","author":"Fagundes","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0104|cit104","unstructured":"Cumpston M Lasserson T Chandler J Page MJ Chapter III: Reporting the review. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/www.cochrane.org\/handbook 2022"},{"key":"10.1002\/14651858.CD009881.pub3-BIB0105|cit105","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2022"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:02:58Z","timestamp":1793066578000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009881.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":105,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009881.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}